Omnicell (OMCL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.The upward trend in estimate revisions for this Omnicell Inc. Reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earning ...

Omnicell (OMCL) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Th ...

Omnicell, Inc. (OMCL) recently introduced OmniSphere, a next-generation, cloud-native software workflow engine and data platform. The new platform is designed to leverage the full power of a cloud-native architecture and seamlessly integrate robotics and smart devices to support more secure, data-driven medication management across the continuum of care. OMCL Stock’s Trend Following the NewsSubsequent to the news, OMCL’s share price moved north marginally by 0.1% to $47.14 Tuesday. Earlier this year, Omnice ...

Omnicell (OMCL) closed the last trading session at $41.82, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $53 indicates a 26.7% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $11.75. While the lowest estimate of $37 indicates a 11.5% decline from the current price level, the most optimistic analyst expects the ...

Omnicell, Inc.'s (OMCL) growth in the third quarter of 2024 can be attributed to the company’s long-term development strategy, driven by innovative solutions, expansion into new markets, strategic partnerships and procurement of new technologies. OMCL is on track to meet its 2025 financial goals, supported by increasing tech services and long-term customer partnerships. Stable solvency buoys optimism. However, a headwind from macroeconomic challenges could adversely impact the company’s performance. In the ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________________________________________________________________________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-33043 ...

Omnicell (OMCL) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this Omnicell Inc. Should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions ...

Michael (Mike) Dion is an FP&A, Corporate Finance, and Small Business expert who spent the last 12 years working in the Fortune 100, building a startup's finance and accounting department, advising small businesses, and guiding non-profit organizations as a board member. He has finance experience across multiple industries, including Telecom, Media and Entertainment, Hospitality, and Construction. He founded F9 Finance, a website that helps Finance professionals accelerate their careers; and simplifies Fina ...

Omnicell, Inc. (OMCL) reported third-quarter 2024 adjusted earnings per share (EPS) of 56 cents, which declined 9.7% year over year. However, the metric beat the Zacks Consensus Estimate by 36.6%.Adjustments include one-time expenses like share-based compensations, the amortization of acquired intangibles, acquisition-related expenses and RDS restructuring.GAAP EPS was 19 cents, up 58.3% from the 2023 figure.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the announcement, O ...

Shares of Omnicell (OMCL) have been strong performers lately, with the stock up 25.4% over the past month. The stock hit a new 52-week high of $55.75 in the previous session. Omnicell has gained 41% since the start of the year compared to the 4.2% move for the Zacks Medical sector and the -47.6% return for the Zacks Medical Info Systems industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of ...